ArticleBreast cancer research : BCR2024

EDI3 knockdown in ER-HER2+ breast cancer cells reduces tumor burden and improves survival in two mouse models of experimental metastasis.

Annika Glotzbach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.